[{"notes_id":"1_2692","category":"5","subcategory":"2","title":"Sickle-cell anaemia: management","body":"Crisis management<br \/><ul><li>analgesia e.g. opiates<\/li><li>rehydrate<\/li><li>oxygen<\/li><li>consider antibiotics if evidence of infection<\/li><li>blood transfusion<\/li><li>exchange transfusion: e.g. if neurological complications<\/li><\/ul><br \/>Longer-term management<br \/><ul><li>hydroxyurea<ul><li><span class=\"concept\" data-cid=\"9888\">increases the HbF levels and is used in the prophylactic management of sickle cell anaemia to prevent painful episodes<\/span><\/li><\/ul><\/li><li>sickle cell patients should receive the <span class=\"concept\" data-cid=\"3283\">pneumococcal polysaccharide vaccine every 5 years<\/span><\/li><\/ul>","notes_hash":"502270ff1e38ea3ecbfbc57e16314bee","knowledge_graph_node_id_link":11033,"links":"","media":"","concepts_for_notes":{"3283":{"concept_text":"Sickle cell patients should receive the pneumococcal polysaccharide vaccine every 5 years","concept_percentile":"42"}},"category_name":"Infectious disease \/ Haematology \/ Immunology","subcategory_name":"Haematology","comment_count":4},"",[]]